Moderna Inc
MRNA
Market Cap$47.02B
Close$
$-72.53
156.2% downside
Current Fair Value
156.2% downsideOvervalued by 156.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $47.02 Billion |
|---|---|
| Enterprise Value | $39.07 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-15.86 |
| Beta | 1.18 |
| Outstanding Shares | 383,239,726 |
| Avg 30 Day Volume | 3,308,286 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -7.88 |
|---|---|
| PEG | 0.5 |
| Price to Sales | 9.93 |
| Price to Book Ratio | 3.91 |
| Enterprise Value to Revenue | 7.58 |
| Enterprise Value to EBIT | -7.6 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
ESG Score
No data
About Moderna Inc
CEO: Stephane Bancel